// App-Quantinova.ai

FRI0193 (2018) : Prognostic markers in axial spondyloarthritis (PROMISE – cross sectional evaluation of serum biomarkers in axspa, mechanical back pain and healthy controls

Researchers

Presenter

  • E. Reilly

Principal Investigators

  • C. Fisher

  • R. Sengupta

Medical Centers

  • Royal National Hospital for Rheumatic Diseases, Bath

  • University College London, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Celgene

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved